A case of prostate cancer with invasion to the middle ureter
Matsuo, T.; Hayashida, Y.; Takehara, K.; Tsuda, S.; Furukawa, M.; Iwasaki, S.
Hinyokika Kiyo. Acta Urologica Japonica 50(1): 61-63
2004
ISSN/ISBN: 0018-1994 PMID: 15032020 Document Number: 571243
A 69-year-old male was diagnosed as having prostate cancer with ureter invasion. His serum prostate specific antigen level was not so high (19.6 ng/ml) before treatment, but clinical stage was D2, poorly differentiated adenocarcinoma of prostate. He was treated with chemoendocrine therapy. Prostate cancer with continuous invasion to the middle ureter is rare. To the best of our knowledge, this is the 6th case report of such an unusual invasion of prostate cancer.
Document emailed within 1 workday
Related Documents
Fariña, L.A.; Iglesias, J.M.; Hocsman, H.; Vicente, R. 1990: Cancer of the prostate with rectal invasion Archivos Espanoles de Urologia 43(9): 1010-1012Sakamoto, S.; Ichikawa, T. 2014: Mechanism of prostate cancer invasion and metastasis Nihon Rinsho. Japanese Journal of Clinical Medicine 72(12): 2086-2089
Ashida, S.; Inoue, K.; Shuin, T. 2016: Molecules associated with invasion and metastasis in prostate cancer Nihon Rinsho. Japanese Journal of Clinical Medicine 74(Suppl 3): 135-139
Jarrard, D.F.; Hansen, N.M.; Patai, B.; Rukstalis, D.B. 1995: Urokinase plasminogen activator is necessary but not sufficient for prostate cancer cell invasion Invasion and Metastasis 15(1-2): 34-45
Zhou, Y.-b.; Zhuo, H.-q.; Li, L.-l.; Lv, L.; Li, Y.-j.; Zhou, J. 2009: A clinical study on the degree of mesorectal tumor invasion in middle-low rectal cancer Zhonghua Wei Chang Wai Ke Za Zhi 12(2): 159-162
Wang, X.; Shi, Z.; Liu, X.; Su, Y.; Li, W.; Dong, H.; Zhao, L.; Li, M.; Wang, Y.; Jin, X.; Huo, Z. 2018: Upregulation of miR-191 promotes cell growth and invasion via targeting TIMP3 in prostate cancer Journal of BUON: Official Journal of the Balkan Union of Oncology 23(2): 444-452
Zheng, W.; Zhang, Y.; Ma, D.; Li, G.; Wang, P. 2011: Anti-invasion effects of R- and S-enantiomers of equol on prostate cancer PC3, DU145 cells Wei Sheng Yan Jiu 40(4): 423-425; 430
Brandon, M.L.; Odom, S.R.; Barone, J.E.; Waxberg, J.A. 2005: Adenocarcinoma of the prostate metastatic to the testis via lymphatic invasion: a case report Connecticut Medicine 69(2): 69-70
Dell'Atti, L. 2016: Prognostic significance of perineural invasion in patients who underwent radical prostatectomy for localized prostate cancer Journal of BUON: Official Journal of the Balkan Union of Oncology 21(5): 1219-1223
Gao, Q.-Q.; Chen, H.; Chen, Y.; Xu, Z.-P.; Zhu, L.-L.; Yu, W.; Han, Y.-F.; Dai, Y.-T. 2016: Effects of the Rho-kinase inhibitor fasudil on the invasion, migration, and apoptosis of human prostate cancer PC3 and DU145 cells Zhonghua Nan Ke Xue 22(6): 483-490
De la Taille, A.; Cao, Y.; Sawczuk, I.S.; Nozemu, T.; d'Agati, V.; McKiernan, J.M.; Bagiella, E.; Buttyan, R.; Burchardt, M.; Olsson, C.A.; Bander, N.; Katz, A.E. 2000: Detection of prostate-specific membrane antigen expressing cells in blood obtained from renal cancer patients: a potential biomarker of vascular invasion Cancer Detection and Prevention 24(6): 579-588
Honda, G.D.; Bernstein, L.; Ross, R.K.; Greenland, S.; Gerkins, V.; Henderson, B.E. 1988: Vasectomy, cigarette smoking, and age at first sexual intercourse as risk factors for prostate cancer in middle-aged men British Journal of Cancer 57(3): 326-331
Matsumura, Y.; Iemura, Y.; Fukui, S.; Kagebayashi, Y.; Samma, S.; Tsujimoto, S.; Okada, T.; Kanno, T. 2018: Ureteral Cancer Developing in Retrocaval Ureter : A Case Report Hinyokika Kiyo. Acta Urologica Japonica 64(1): 13-16
Murray, N.P.; Aedo, S.óc.; Reyes, E.; Fuentealba, C.; Jacob, O. 2019: Primary circulating prostate cells, age and prostatic volumen predict the presence of prostate cancer in men with indication of a second prostate biopsy Archivos Espanoles de Urologia 72(1): 16-24
Romppanen, J.; Haapalainen, T.; Punnonen, K.; Penttilä, I. 2002: Serum sialic acid and prostate-specific antigen in differential diagnosis of benign prostate hyperplasia and prostate cancer Anticancer Research 22(1a): 415-420
Delrio, P.; Fazioli, F.; Di Marzo, M.; Avallone, A.; Elmo, M.; Pecori, B.; Ravo, V.; Idà, D.N.; Bianchi, P.; Cremona, F.; De Rosa, V.; Parisi, V. 2005: Combined multistep approach in a locally advanced rectal cancer with sacral invasion: case report I Supplementi di Tumori: Official Journal of Societa Italiana di Cancerologia . 4(3): S7
Haba, Y.; Okamoto, K.; Watanabe, T.; Tsukada, T.; Kinoshita, J.; Makino, I.; Nakamura, K.; Oyama, K.; Ninomiya, I.; Fushida, S.; Fujimura, T.; Ohta, T. 2014: A case of advanced esophageal cancer with direct bronchial invasion successfully treated by multidisciplinary therapy Gan to Kagaku Ryoho. Cancer and ChemoTherapy 41(12): 2019-2020
Sun, S.-C.; Zhao, H.; Liu, R.; Wang, B.-L.; Liu, Y.-Q.; Zhao, Y.; Shi, Z.-D. 2017: Expression of long non-coding RNA H19 in prostate cancer and its effect on the proliferation and glycometabolism of human prostate cancer cells Zhonghua Nan Ke Xue 23(2): 120-124
Considine, B.; Petrylak, D.P. 2019: Integrating Novel Targets and Precision Medicine into Prostate Cancer Care-Part 1: the Non-Androgen-Targetable Pathways in Castration-Resistant Prostate Cancer Oncology 33(3): 113-118
Grosclaude, P.; Menegoz, F.; Schaffer, P.; Macé Lesec'h, J.; Arveux, P.; Le Mab, G.; Soulié, M.; Villers, A. 1997: Prostate cancer screening (II): is prostate cancer a public health problem? Update of incidence and mortality figures in France from 1982 to 1990 Progres en Urologie: Journal de l'Association Francaise d'Urologie et de la Societe Francaise d'Urologie 7(4): 647-654